Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PRV 3279

Next Previous
Drug Profile

PRV 3279

Alternative Names: Anti-CD32B-anti-CD79B-bispecific-monoclonal-antibody; CD32BxCD79B; MGD 010; PRV-3279

Latest Information Update: 06 May 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator MacroGenics
  • Developer Provention Bio
  • Class Anti-inflammatories; Antineoplastics; Bispecific antibodies; Monoclonal antibodies
  • Mechanism of Action Fc gamma receptor IIA antagonists; Fc gamma receptor IIB antagonists; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Systemic lupus erythematosus
  • No development reported Autoimmune disorders

Most Recent Events

  • 25 Apr 2025 Provention Bio terminates a phase II trial in Systemic lupus erythematosus in USA, Puerto Rico, China (IV) due to change in strategy (NCT05087628)
  • 28 Sep 2024 No recent reports of development identified for preclinical development in Autoimmune-disorders in USA (IV)
  • 27 Apr 2023 Provention Bio has been acquired by Sanofi

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top